Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial [NA]

View source ↗

Summary

The CardiAMP Cell Therapy trial for refractory angina and chronic myocardial ischemia remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CardiAMP Cell Therapy

Snippet

Sponsor: BioCardia, Inc. | Conditions: Refractory Angina, Chronic Myocardial Ischemia | NA | Status: ACTIVE_NOT_RECRUITING